In another study, El Sewefy et al. showed that hepcidin levels ≥ 280 ng/mL had an 83% accuracy in discriminating ESA-resistant from -responsive HD patients, reinforcing its diagnostic potential [48]. This evidence concerns the gene HAMP and Huntington disease.